Besides, the expression of miR-23a in lung cancer-derived exosomes under hypoxic conditions enhances angiogenesis by targeting prolyl hydroxylase 1 and 2 (PHD1 and 2), inducing HIF-1 α and, consequently, activating the VEGF pathway. The gene discussed is SETD2; the disease is lung carcinoma.